These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 21204728

  • 1. The kinase NIK as a therapeutic target in multiple myeloma.
    Gardam S, Beyaert R.
    Expert Opin Ther Targets; 2011 Feb; 15(2):207-18. PubMed ID: 21204728
    [Abstract] [Full Text] [Related]

  • 2. NIK controls classical and alternative NF-κB activation and is necessary for the survival of human T-cell lymphoma cells.
    Odqvist L, Sánchez-Beato M, Montes-Moreno S, Martín-Sánchez E, Pajares R, Sánchez-Verde L, Ortiz-Romero PL, Rodriguez J, Rodríguez-Pinilla SM, Iniesta-Martínez F, Solera-Arroyo JC, Ramos-Asensio R, Flores T, Palanca JM, Bragado FG, Franjo PD, Piris MA.
    Clin Cancer Res; 2013 May 01; 19(9):2319-30. PubMed ID: 23536439
    [Abstract] [Full Text] [Related]

  • 3. Overexpression of NF-κB inducing kinase underlies constitutive NF-κB activation in lung cancer cells.
    Saitoh Y, Martínez Bruyn VJ, Uota S, Hasegawa A, Yamamoto N, Imoto I, Inazawa J, Yamaoka S.
    Lung Cancer; 2010 Dec 01; 70(3):263-70. PubMed ID: 20338663
    [Abstract] [Full Text] [Related]

  • 4. Functional interplay between NF-κB-inducing kinase and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma.
    Mazzera L, Abeltino M, Lombardi G, Cantoni AM, Ria R, Ricca M, Saltarella I, Naponelli V, Rizzi FMA, Perris R, Corradi A, Vacca A, Bonati A, Lunghi P.
    Haematologica; 2019 Dec 01; 104(12):2465-2481. PubMed ID: 30948493
    [Abstract] [Full Text] [Related]

  • 5. Tanshinone IIA inhibits LPS-induced NF-kappaB activation in RAW 264.7 cells: possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathways.
    Jang SI, Kim HJ, Kim YJ, Jeong SI, You YO.
    Eur J Pharmacol; 2006 Aug 07; 542(1-3):1-7. PubMed ID: 16797002
    [Abstract] [Full Text] [Related]

  • 6. Defective lymphotoxin-beta receptor-induced NF-kappaB transcriptional activity in NIK-deficient mice.
    Yin L, Wu L, Wesche H, Arthur CD, White JM, Goeddel DV, Schreiber RD.
    Science; 2001 Mar 16; 291(5511):2162-5. PubMed ID: 11251123
    [Abstract] [Full Text] [Related]

  • 7. The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway.
    Ninomiya-Tsuji J, Kishimoto K, Hiyama A, Inoue J, Cao Z, Matsumoto K.
    Nature; 1999 Mar 18; 398(6724):252-6. PubMed ID: 10094049
    [Abstract] [Full Text] [Related]

  • 8. Protective effect of Ginkgolids (A+B) is associated with inhibition of NIK/IKK/IkappaB/NF-kappaB signaling pathway in a rat model of permanent focal cerebral ischemia.
    Wang X, Qin ZH, Shi H, Savitz SI, Qin AP, Jiang Y, Zhang HL.
    Brain Res; 2008 Oct 09; 1234():8-15. PubMed ID: 18722355
    [Abstract] [Full Text] [Related]

  • 9. TNF/IL-1/NIK/NF-kappa B transduction pathway: a comparative study in normal and pathological human prostate (benign hyperplasia and carcinoma).
    Nuñez C, Cansino JR, Bethencourt F, Pérez-Utrilla M, Fraile B, Martínez-Onsurbe P, Olmedilla G, Paniagua R, Royuela M.
    Histopathology; 2008 Aug 09; 53(2):166-76. PubMed ID: 18752500
    [Abstract] [Full Text] [Related]

  • 10. NIK is a component of the EGF/heregulin receptor signaling complexes.
    Chen D, Xu LG, Chen L, Li L, Zhai Z, Shu HB.
    Oncogene; 2003 Jul 10; 22(28):4348-55. PubMed ID: 12853971
    [Abstract] [Full Text] [Related]

  • 11. Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma.
    Annunziata CM, Davis RE, Demchenko Y, Bellamy W, Gabrea A, Zhan F, Lenz G, Hanamura I, Wright G, Xiao W, Dave S, Hurt EM, Tan B, Zhao H, Stephens O, Santra M, Williams DR, Dang L, Barlogie B, Shaughnessy JD, Kuehl WM, Staudt LM.
    Cancer Cell; 2007 Aug 10; 12(2):115-30. PubMed ID: 17692804
    [Abstract] [Full Text] [Related]

  • 12. Induction of nuclear factor-kappaB activation through TAK1 and NIK by diesel exhaust particles in L2 cell lines.
    Yun YP, Joo JD, Lee JY, Nam HY, Kim YH, Lee KH, Lim CS, Kim HJ, Lim YG, Lim Y.
    Toxicol Lett; 2005 Feb 15; 155(2):337-42. PubMed ID: 15603929
    [Abstract] [Full Text] [Related]

  • 13. Molecular mediators of alphavbeta3-induced endothelial cell survival.
    Rice J, Courter DL, Giachelli CM, Scatena M.
    J Vasc Res; 2006 Feb 15; 43(5):422-36. PubMed ID: 16888388
    [Abstract] [Full Text] [Related]

  • 14. TACI induces cIAP1-mediated ubiquitination of NIK by TRAF2 and TANK to limit non-canonical NF-kappaB signaling.
    Kanno Y, Sakurai D, Hase H, Kojima H, Kobata T.
    J Recept Signal Transduct Res; 2010 Apr 15; 30(2):121-32. PubMed ID: 20184394
    [Abstract] [Full Text] [Related]

  • 15. Regulation of late B cell differentiation by intrinsic IKKalpha-dependent signals.
    Mills DM, Bonizzi G, Karin M, Rickert RC.
    Proc Natl Acad Sci U S A; 2007 Apr 10; 104(15):6359-64. PubMed ID: 17404218
    [Abstract] [Full Text] [Related]

  • 16. Non-canonical NF-κB signaling activation and regulation: principles and perspectives.
    Razani B, Reichardt AD, Cheng G.
    Immunol Rev; 2011 Nov 10; 244(1):44-54. PubMed ID: 22017430
    [Abstract] [Full Text] [Related]

  • 17. HIV-1 Tat protein induces IL-10 production in monocytes by classical and alternative NF-kappaB pathways.
    Leghmari K, Bennasser Y, Bahraoui E.
    Eur J Cell Biol; 2008 Dec 10; 87(12):947-62. PubMed ID: 18760861
    [Abstract] [Full Text] [Related]

  • 18. Novel inhibitors are cytotoxic for myeloma cells with NFkB inducing kinase-dependent activation of NFkB.
    Demchenko YN, Brents LA, Li Z, Bergsagel LP, McGee LR, Kuehl MW.
    Oncotarget; 2014 Jun 30; 5(12):4554-66. PubMed ID: 24980832
    [Abstract] [Full Text] [Related]

  • 19. [Molecular pathogenesis of myeloma for the therapeutic targets].
    Hanamura I.
    Nihon Rinsho; 2007 Dec 30; 65(12):2202-8. PubMed ID: 18069261
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK).
    Zhang S, Shan C, Kong G, Du Y, Ye L, Zhang X.
    Oncogene; 2012 Aug 02; 31(31):3607-20. PubMed ID: 22105365
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.